Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) EBIT (2016 - 2020)

Historic EBIT for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$8.7 million.

  • Forte Biosciences' EBIT rose 4845.0% to -$8.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$53.3 million, marking a year-over-year decrease of 693.28%. This contributed to the annual value of -$61.5 million for FY2019, which is 3414.83% down from last year.
  • As of Q1 2020, Forte Biosciences' EBIT stood at -$8.7 million, which was up 4845.0% from -$10.7 million recorded in Q4 2019.
  • Forte Biosciences' 5-year EBIT high stood at $1.4 million for Q3 2018, and its period low was -$19.1 million during Q4 2018.
  • For the 5-year period, Forte Biosciences' EBIT averaged around -$10.9 million, with its median value being -$9.7 million (2017).
  • Per our database at Business Quant, Forte Biosciences' EBIT surged by 11465.54% in 2018 and then crashed by 129992.99% in 2019.
  • Forte Biosciences' EBIT (Quarter) stood at -$8.0 million in 2016, then crashed by 34.04% to -$10.7 million in 2017, then tumbled by 78.8% to -$19.1 million in 2018, then surged by 43.99% to -$10.7 million in 2019, then grew by 18.73% to -$8.7 million in 2020.
  • Its EBIT stands at -$8.7 million for Q1 2020, versus -$10.7 million for Q4 2019 and -$17.1 million for Q3 2019.